Treatment of Acrodermatitis Continua of Hallopeau With Ustekinumab as Monotherapy

Abstract

to improve in the next days (Figure Two weeks after amino acid treatment, radiolabeled somatostatin analogue therapy was given to induce tumor reduction and allow for tumor resection without affecting the adjacent blood vessels.